PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
DPLM.L vs. WST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between DPLM.L and WST is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

DPLM.L vs. WST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Diploma plc (DPLM.L) and West Pharmaceutical Services, Inc. (WST). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%15.00%JulyAugustSeptemberOctoberNovemberDecember
4.50%
1.14%
DPLM.L
WST

Key characteristics

Sharpe Ratio

DPLM.L:

0.93

WST:

-0.22

Sortino Ratio

DPLM.L:

1.42

WST:

-0.04

Omega Ratio

DPLM.L:

1.19

WST:

0.99

Calmar Ratio

DPLM.L:

2.15

WST:

-0.21

Martin Ratio

DPLM.L:

4.98

WST:

-0.43

Ulcer Index

DPLM.L:

4.72%

WST:

19.49%

Daily Std Dev

DPLM.L:

25.10%

WST:

38.78%

Max Drawdown

DPLM.L:

-81.06%

WST:

-55.52%

Current Drawdown

DPLM.L:

-5.66%

WST:

-30.49%

Fundamentals

Market Cap

DPLM.L:

£5.91B

WST:

$24.21B

EPS

DPLM.L:

£0.96

WST:

$6.75

PE Ratio

DPLM.L:

45.48

WST:

49.52

PEG Ratio

DPLM.L:

2.49

WST:

6.24

Total Revenue (TTM)

DPLM.L:

£638.30M

WST:

$2.88B

Gross Profit (TTM)

DPLM.L:

£292.60M

WST:

$1.00B

EBITDA (TTM)

DPLM.L:

£133.50M

WST:

$743.90M

Returns By Period

In the year-to-date period, DPLM.L achieves a 24.01% return, which is significantly higher than WST's -7.39% return. Over the past 10 years, DPLM.L has outperformed WST with an annualized return of 21.92%, while WST has yielded a comparatively lower 20.10% annualized return.


DPLM.L

YTD

24.01%

1M

-3.66%

6M

5.71%

1Y

25.06%

5Y*

18.38%

10Y*

21.92%

WST

YTD

-7.39%

1M

5.89%

6M

1.14%

1Y

-8.99%

5Y*

16.96%

10Y*

20.10%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DPLM.L vs. WST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Diploma plc (DPLM.L) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for DPLM.L, currently valued at 0.79, compared to the broader market-4.00-2.000.002.000.79-0.22
The chart of Sortino ratio for DPLM.L, currently valued at 1.24, compared to the broader market-4.00-2.000.002.004.001.24-0.04
The chart of Omega ratio for DPLM.L, currently valued at 1.17, compared to the broader market0.501.001.502.001.170.99
The chart of Calmar ratio for DPLM.L, currently valued at 1.46, compared to the broader market0.002.004.006.001.46-0.20
The chart of Martin ratio for DPLM.L, currently valued at 3.89, compared to the broader market0.0010.0020.003.89-0.42
DPLM.L
WST

The current DPLM.L Sharpe Ratio is 0.93, which is higher than the WST Sharpe Ratio of -0.22. The chart below compares the historical Sharpe Ratios of DPLM.L and WST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
0.79
-0.22
DPLM.L
WST

Dividends

DPLM.L vs. WST - Dividend Comparison

DPLM.L's dividend yield for the trailing twelve months is around 1.31%, more than WST's 0.25% yield.


TTM20232022202120202019201820172016201520142013
DPLM.L
Diploma plc
1.31%1.54%1.62%0.37%1.37%1.43%2.11%1.84%1.92%2.39%2.40%2.33%
WST
West Pharmaceutical Services, Inc.
0.25%0.22%0.31%0.15%0.23%0.41%0.58%0.54%0.58%0.75%0.77%0.78%

Drawdowns

DPLM.L vs. WST - Drawdown Comparison

The maximum DPLM.L drawdown since its inception was -81.06%, which is greater than WST's maximum drawdown of -55.52%. Use the drawdown chart below to compare losses from any high point for DPLM.L and WST. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-9.86%
-30.49%
DPLM.L
WST

Volatility

DPLM.L vs. WST - Volatility Comparison

Diploma plc (DPLM.L) and West Pharmaceutical Services, Inc. (WST) have volatilities of 7.27% and 7.07%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
7.27%
7.07%
DPLM.L
WST

Financials

DPLM.L vs. WST - Financials Comparison

This section allows you to compare key financial metrics between Diploma plc and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. DPLM.L values in GBp, WST values in USD
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab